Knightsbridge Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Knightsbridge Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.14M	Hold	6,750	–	–	0.15%	72
2025 Q4	$1.14M	Hold	6,750	–	–	0.18%	68
2025 Q3	$974K	Sell	6,750 -390	-5%	-$53.2K	0.16%	71
2025 Q2	$903K	Buy	7,140 +450	+7%	+$55.2K	0.2%	65
2025 Q1	$856K	Sell	6,690 -1,335	-17%	-$181K	0.22%	63
2024 Q4	$1.06M	Sell	8,025 -72	-0.9%	-$10.1K	0.25%	59
2024 Q3	$1.18M	Hold	8,097	–	–	0.26%	58
2024 Q2	$1.11M	Sell	8,097 -93	-1%	-$12.4K	0.28%	58
2024 Q1	$1.11M	Hold	8,190	–	–	0.31%	57
2023 Q4	$1.11M	Sell	8,190 -510	-6%	-$62.2K	0.31%	57
2023 Q3	$1.06M	Hold	8,700	–	–	0.34%	57
2023 Q2	$1.1M	Sell	8,700 -8,700	-50%	-$1.13M	0.36%	56
2023 Q1	$2.25M	Hold	17,400	–	–	0.38%	55
2022 Q4	$2.28M	Hold	17,400	–	–	0.43%	55
2022 Q3	$2.04M	Hold	17,400	–	–	0.43%	50
2022 Q2	$2.05M	Buy	17,400 +7,750	+80%	+$920K	0.41%	50
2022 Q1	$1.26M	Hold	9,650	–	–	0.42%	52
2021 Q4	$1.47M	Hold	9,650	–	–	0.49%	50
2021 Q3	$1.56M	Sell	9,650 -700	-7%	-$118K	0.55%	45
2021 Q2	$1.69M	Hold	10,350	–	–	0.66%	35
2021 Q1	$1.56M	Hold	10,350	–	–	0.66%	33
2020 Q4	$1.57M	Hold	10,350	–	–	0.77%	29
2020 Q3	$1.4M	Hold	10,350	–	–	0.81%	29
2020 Q2	$1.42M	Buy	+10,350	New	+$1.32M	0.92%	26

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Knightsbridge Asset Management's IBB Position: Q1 2026 in Review

Knightsbridge Asset Management held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 6,750 shares worth $1.14M. The position accounts for 0.15% of the portfolio, ranked #72.

Knightsbridge Asset Management first reported a position in IBB in Q2 2020 and has held it in 24 quarters since. The position peaked at $2.28M in Q4 2022. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Knightsbridge Asset Management held 6,750 shares of iShares Biotechnology ETF worth $1.14M as of Q1 2026.
Knightsbridge Asset Management left its iShares Biotechnology ETF share count unchanged in Q1 2026.
iShares Biotechnology ETF made up 0.15% of Knightsbridge Asset Management's portfolio in Q1 2026, its #72 holding.
Knightsbridge Asset Management first reported a position in iShares Biotechnology ETF in Q2 2020 and has held it in 24 quarters since.
Knightsbridge Asset Management's iShares Biotechnology ETF position peaked at $2.28M in Q4 2022.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Knightsbridge Asset Management's 13F filing for Q1 2026, filed 15 May 2026.